.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fish and Richardson
Fuji
Merck
McKinsey
US Army
Dow
Citi
Mallinckrodt
Boehringer Ingelheim
AstraZeneca

Generated: February 21, 2018

DrugPatentWatch Database Preview

Details for Patent: ➤ Sign Up

« Back to Dashboard

Details for Patent: ➤ Sign Up

Title: Oral 2-methyl-thieno-benzodiazepine formulation
Abstract:The invention provides a pharmaceutically acceptable solid oral formulation of olanzapine and a process for making such formulation.
Inventor(s): Cochran; George Randall (Indianapolis, IN), Morris; Tommy Clifford (Indianapolis, IN)
Assignee: Eli Lilly and Company (Indianapolis, IN)
Filing Date:Aug 31, 1998
Application Number:09/144,188
Claims:1. A solid oral formulation consisting essentially of olanzapine as an active ingredient intimately mixed with lactose, hydroxypropyl cellulose, crospovidone, microcrystalline cellulose, and magnesium stearate; wherein said solid oral formulation is coated with hydroxypropyl methyl cellulose, said hydroxypropyl methyl cellulose is further coated with an aqueous dispersion film coat and said solid oral formulation is imprinted using an edible ink.

2. A formulation as claimed in claim 1 wherein Olanzapine is substantially pure Form II polymorph having a typical X-ray powder diffraction pattern as represented by the following interplanar spacings

TBL d 10.2689 8.577 7.4721 7.125 6.1459 6.071 5.4849 5.2181 5.1251 4.9874 4.7665 4.7158 4.4787 4.3307 4.2294 4.141 3.9873 3.7206 3.5645 3.5366 3.3828 3.2516 3.134 3.0848 3.0638 3.0111 2.8739 2.8102 2.7217 2.6432 2.6007.
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

UBS
Dow
Chinese Patent Office
Queensland Health
US Department of Justice
Boehringer Ingelheim
Johnson and Johnson
Fish and Richardson
Deloitte
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot